CXCR2 and hepatocellular carcinoma: Taking the median percentage of CXCR2+ monocytes (78.76%) as the cutoff value, the patients with HCC were divided into two groups (CXCR2+ low and CXCR2+ high), and the differences in clinicopathological characteristics of the two groups were compared.